Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▲ |
|---|---|---|---|
| 5Y92 | Q3E8W4 | Crystal structure of ANXUR2 extracellular domain from Arabidopsis thaliana | Receptor-like protein kinase ANXUR2 (E.C.2.7.11.1) |
| 6FIH | Q3E8W4 | Crystal structure of the ANX2 ectodomain from Arabidopsis thaliana | Receptor-like protein kinase ANXUR2 (E.C.2.7.11.1) |
| 6A5E | Q9SCZ4 | Crystal structure of plant peptide RALF23 in complex with FER and LLG2 | Receptor-like protein kinase FERONIA (E.C.2.7.11.1), GPI-anchored protein LLG2, R |
| 6A5E | Q6NLF4 | Crystal structure of plant peptide RALF23 in complex with FER and LLG2 | Receptor-like protein kinase FERONIA (E.C.2.7.11.1), GPI-anchored protein LLG2, R |
| 6A5E | 6A5E | Crystal structure of plant peptide RALF23 in complex with FER and LLG2 | Receptor-like protein kinase FERONIA (E.C.2.7.11.1), GPI-anchored protein LLG2, R |
| 5WY8 | P23468 | Crystal structure of PTP delta Ig1-Ig3 in complex with IL1RAPL1 Ig1-Ig3 | Receptor-type tyrosine-protein phosphatase delta (E.C.3.1.3.48), Interleukin-1 receptor accessory protein-like 1 |
| 5WY8 | Q9NZN1 | Crystal structure of PTP delta Ig1-Ig3 in complex with IL1RAPL1 Ig1-Ig3 | Receptor-type tyrosine-protein phosphatase delta (E.C.3.1.3.48), Interleukin-1 receptor accessory protein-like 1 |
| 5XWU | Q64487 | Crystal structure of PTPdelta Ig1-Ig3 in complex with SALM2 LRR-Ig | Receptor-type tyrosine-protein phosphatase delta (E.C.3.1.3.48), Leucine-rich repeat and fibronectin type III domain-containing protein 1 |
| 5XWU | Q2WF71 | Crystal structure of PTPdelta Ig1-Ig3 in complex with SALM2 LRR-Ig | Receptor-type tyrosine-protein phosphatase delta (E.C.3.1.3.48), Leucine-rich repeat and fibronectin type III domain-containing protein 1 |
| 5XWT | Q64487 | Crystal structure of PTPdelta Ig1-Fn1 in complex with SALM5 LRR-Ig | Receptor-type tyrosine-protein phosphatase delta (E.C.3.1.3.48), Leucine-rich repeat and fibronectin type-III domain-containing protein 5 |
| 5XWT | Q96NI6 | Crystal structure of PTPdelta Ig1-Fn1 in complex with SALM5 LRR-Ig | Receptor-type tyrosine-protein phosphatase delta (E.C.3.1.3.48), Leucine-rich repeat and fibronectin type-III domain-containing protein 5 |
| 5B4X | Q60841 | Crystal structure of the ApoER2 ectodomain in complex with the Reelin R56 fragment | Reelin (E.C.3.4.21.-), Low density lipoprotein receptor-related protein 8, apolipoprotein e receptor, isoform CRA_e |
| 5B4X | D3DQ39 | Crystal structure of the ApoER2 ectodomain in complex with the Reelin R56 fragment | Reelin (E.C.3.4.21.-), Low density lipoprotein receptor-related protein 8, apolipoprotein e receptor, isoform CRA_e |
| 5TMG | P00797 | Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | Renin (E.C.3.4.23.15) |
| 5TMK | P00797 | Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | Renin (E.C.3.4.23.15) |
| 5SXN | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | Renin (E.C.3.4.23.15) |
| 5SY2 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | Renin (E.C.3.4.23.15) |
| 5SY3 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | Renin (E.C.3.4.23.15) |
| 5SZ9 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | Renin (E.C.3.4.23.15) |
| 5T4S | P00797 | Novel Approach of Fragment-Based Lead Discovery applied to Renin Inhibitors | Renin (E.C.3.4.23.15) |
| 5VPM | P00797 | Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol | Renin (E.C.3.4.23.15) |
| 5VRP | P00797 | Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol | Renin (E.C.3.4.23.15) |
| 2G1N | P00797 | Ketopiperazine-based renin inhibitors: Optimization of the "C" ring | Renin (E.C.3.4.23.15) |
| 2G1O | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring | Renin (E.C.3.4.23.15) |
| 2G1R | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring | Renin (E.C.3.4.23.15) |
| 2G1S | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring | Renin (E.C.3.4.23.15) |
| 2G1Y | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring | Renin (E.C.3.4.23.15) |
| 2G22 | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring | Renin (E.C.3.4.23.15) |
| 3G6Z | P00797 | Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors | Renin (E.C.3.4.23.15) |
| 3G70 | P00797 | Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors | Renin (E.C.3.4.23.15) |
| 3G72 | P00797 | Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors | Renin (E.C.3.4.23.15) |
| 3K1W | P00797 | New Classes of Potent and Bioavailable Human Renin Inhibitors | Renin (E.C.3.4.23.15) |
| 3OAD | P00797 | Design and optimization of new piperidines as renin inhibitors | Renin (E.C.3.4.23.15) |
| 3OAG | P00797 | Design and optimization of new piperidines as renin inhibitors | Renin (E.C.3.4.23.15) |
| 3OOT | P00797 | Crystal Structure Analysis of Renin-indole-piperazin inhibitor complexes | Renin (E.C.3.4.23.15) |
| 3OQF | P00797 | Crystal Structure Analysis of Renin-indole-piperazine inhibitor complexes | Renin (E.C.3.4.23.15) |
| 3OQK | P00797 | Crystal Structure Analysis of Renin-indole-piperazin inhibitor complexes | Renin (E.C.3.4.23.15) |
| 3SFC | P00797 | Structure-Based Optimization of Potent 4- and 6-Azaindole-3-Carboxamides as Renin Inhibitors | Renin (E.C.3.4.23.15) |
| 4PYV | P00797 | Crystal structure of renin in complex with compound4 | Renin (E.C.3.4.23.15) |
| 4Q1N | P00797 | Structure-based design of 4-hydroxy-3,5-substituted piperidines as direct renin inhibitors | Renin (E.C.3.4.23.15) |
| 4RYC | P00797 | RENIN IN COMPLEXED WITH 4-methoxy-3-(3-methoxypropoxy)-N-{[(3S,4S)-4-{[(4-methylphenyl)sulfonyl]amino}pyrrolidin-3-yl]methyl}-N-(propan-2-yl)benzamide INHIBITOR | Renin (E.C.3.4.23.15) |
| 4RYG | P00797 | RENIN IN COMPLEXED WITH N-({(3S,4S)-4-[(benzylsulfonyl)amino]pyrrolidin-3-yl}methyl)-4-methoxy-3-(3-methoxypropoxy)-N-(propan-2-yl)benzamide INHIBITOR | Renin (E.C.3.4.23.15) |
| 4RZ1 | P00797 | RENIN IN COMPLEXED WITH (3S,4S)-4-({[4-methoxy-3-(3-methoxypropoxy)benzoyl](propan-2-yl)amino}methyl)pyrrolidin-3-yl benzylcarbamate INHIBITOR | Renin (E.C.3.4.23.15) |
| 4S1G | P00797 | Renin in complex with (S)-1-(3-fluoro-5-(((S)-1-phenylethyl)carbamoyl)benzyl)-4-isopropyl-4-methyl-6-oxotetrahydropyrimidin-2(1H)-iminium | Renin (E.C.3.4.23.15) |
| 5KOQ | P00797 | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | Renin (E.C.3.4.23.15) |
| 5KOS | P00797 | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | Renin (E.C.3.4.23.15) |
| 5KOT | P00797 | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | Renin (E.C.3.4.23.15) |
| 3O9L | P00797 | Design and optimisation of new piperidines as renin inhibitors | Renin (E.C.3.4.23.15), Renin (E.C.3.4.23.15) |
| 6VEJ | 6VEJ | TriABC transporter from Pseudomonas aeruginosa | Resistance-nodulation-cell division (RND) efflux transporter, Resistance-nodulation-cell division (RND) efflux membrane fusion protein |
| 6VEJ | Q9I6X5 | TriABC transporter from Pseudomonas aeruginosa | Resistance-nodulation-cell division (RND) efflux transporter, Resistance-nodulation-cell division (RND) efflux membrane fusion protein |
